Teriflunomide
Teriflunomide (A 77-1726) is the primary active metabolite derived from leflunomide, a drug approved for treating rheumatoid arthritis and multiple sclerosis. This small molecule inhibitor of dihydroorotate dehydrogenase is widely used in immunology and neurology research, facilitating both in vitro cellular studies and in vivo disease modeling.
Product Specifications
CAS Number
163451-81-8
Product Name Alternative
A77 1726, A 77-1726, Inhibitor, inhibit, Teriflunomide
Field of Research
Metabolism Research, Pharmacology & Drug Discovery
Purity
99.54% (May vary between batches)
Solubility
DMSO:29.41 mg/mL (108.84 mM) ;10% DMSO+40% PEG300+5% Tween 80+45% Saline:2 mg/mL (7.4 mM)
Smiles
C (F) (F) (F) C1=CC=C (NC (/C (=C (/C) \O) /C#N) =O) C=C1
Molecular Formula
C12H9F3N2O2
Molecular Weight
270.21
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
A08922-3-Dylight550 100 µg
Anti-RPL36 Antibody Picoband®, Dylight550 Conjugate
Sign In for Pricing
View Details 
MBS1452191-01 0.02 mg (E-Coli)
Recombinant Rhodopseudomonas palustris NADH-quinone oxidoreductase subunit B 1 (nuoB1)
Sign In for Pricing
View Details 
MBS1452191-02 0.1 mg (E-Coli)
Recombinant Rhodopseudomonas palustris NADH-quinone oxidoreductase subunit B 1 (nuoB1)
Sign In for Pricing
View Details